OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DETEC58

Detection Technology Oyj

Advanced Medical Equipment & TechnologyVerified

Detection Technology Oyj maintains a strong liquidity position, with a current ratio of 3.44 and cash and equivalents of EUR 24.98 million, which supports its short-term obligations. The company's debt-to-equity ratio is 0.06, indicating a conservative capital structure with minimal leverage. Free cash flow for the period was EUR 397,130, which is modest but positive, and capital expenditures were negative at EUR -1.60 million, suggesting a reduction in investment in physical assets. In terms of profitability, the company reported a return on equity (ROE) of 8.24% and a return on assets (ROA) of 6.19%, both of which are below the industry median for Advanced Medical Equipment & Technology firms. The net income of EUR 6.44 million and operating income of EUR 8.13 million reflect a healthy but not exceptional performance relative to peers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to regional economic or regulatory risks. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure outlook is neutral, with no major investment plans disclosed. The R&D outlook is also stable, with no material changes expected in the near term. The company's risk profile is low, with no immediate liquidity or dilution concerns. The dilution potential is minimal, as the number of shares outstanding has not changed between basic and diluted shares. No recent filings or transcripts indicate material risk events or strategic shifts. Recent analyst estimates suggest a generally positive outlook, with a mean price target of EUR 11.93 and a median of EUR 12.00. The mean recommendation score of 1.80 indicates a slight bias toward a "buy" rating, with three strong buy and two hold recommendations.

30-day price · DETEC-0.44 (-4.8%)
Low$8.52High$9.90Close$8.66As of15 May, 00:00 UTC
Profile
CompanyDetection Technology Oyj
TickerDETEC.HE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Detection Technology Oyj develops and sells advanced medical equipment and technology, primarily focused on diagnostic and monitoring solutions for healthcare providers.

Classification. The company is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a high confidence level of 0.92.

Detection Technology Oyj maintains a strong liquidity position, with a current ratio of 3.44 and cash and equivalents of EUR 24.98 million, which supports its short-term obligations. The company's debt-to-equity ratio is 0.06, indicating a conservative capital structure with minimal leverage. Free cash flow for the period was EUR 397,130, which is modest but positive, and capital expenditures were negative at EUR -1.60 million, suggesting a reduction in investment in physical assets. In terms of profitability, the company reported a return on equity (ROE) of 8.24% and a return on assets (ROA) of 6.19%, both of which are below the industry median for Advanced Medical Equipment & Technology firms. The net income of EUR 6.44 million and operating income of EUR 8.13 million reflect a healthy but not exceptional performance relative to peers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to regional economic or regulatory risks. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure outlook is neutral, with no major investment plans disclosed. The R&D outlook is also stable, with no material changes expected in the near term. The company's risk profile is low, with no immediate liquidity or dilution concerns. The dilution potential is minimal, as the number of shares outstanding has not changed between basic and diluted shares. No recent filings or transcripts indicate material risk events or strategic shifts. Recent analyst estimates suggest a generally positive outlook, with a mean price target of EUR 11.93 and a median of EUR 12.00. The mean recommendation score of 1.80 indicates a slight bias toward a "buy" rating, with three strong buy and two hold recommendations.
Key takeaways
  • Detection Technology Oyj maintains a conservative capital structure with a low debt-to-equity ratio and strong liquidity.
  • The company's profitability metrics are in line with industry norms but not exceptional.
  • Revenue and geographic diversification are limited, which could increase exposure to regional risks.
  • Analysts are cautiously optimistic, with a mean price target of EUR 11.93 and a slight buy bias.
  • No immediate liquidity or dilution risks are present, and the company's risk profile is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$101.0M
Gross profit$45.2M
Operating income$8.1M
Net income$6.4M
R&D
SG&A
D&A
SBC
Operating cash flow$3.9M
CapEx-$1.6M
Free cash flow$397.1k
Total assets$104.1M
Total liabilities$25.9M
Total equity$78.2M
Cash & equivalents$25.0M
Long-term debt$4.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$78.2M
Net cash$20.5M
Current ratio3.4
Debt/Equity0.1
ROA6.2%
ROE8.2%
Cash conversion60.0%
CapEx/Revenue-1.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricDETECActivity
Op margin8.0%-16.5% medp25 -174.5% · p75 8.8%above median
Net margin6.4%-16.5% medp25 -172.4% · p75 8.4%above median
Gross margin44.8%47.4% medp25 34.2% · p75 65.3%below median
CapEx / revenue-1.6%-5.4% medp25 -12.5% · p75 -2.2%top quartile
Debt / equity6.0%4.3% medp25 0.0% · p75 28.0%above median
Observations
IR observations
Mean price target11.93 EUR
Median price target12.00 EUR
High price target13.20 EUR
Low price target10.50 EUR
Mean recommendation1.80 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count0.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.64 EUR
Last actual EPS0.44 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 01:09 UTC#72f856b2
Market quoteclose EUR 8.60 · shares 0.01B diluted
no public URL
2026-05-15 01:11 UTC#9e19842c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 18:26 UTCJob: 6eea2256